Center for Scientific Review; Notice of Closed Meeting, 86139 [2023-27198]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 237 / Tuesday, December 12, 2023 / Notices
Dated: December 7, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023–27238 Filed 12–11–23; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Office
of Readiness and Response
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with regulatory
provisions, the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
Board of Scientific Counselors, Office of
Readiness and Response (BSC, ORR).
This virtual meeting is open to the
public, limited only by the number of
web conference lines available (500
lines). Registration in advance is
required by accessing the link below in
the addresses section. Time will be
available for public comment.
DATES: The meeting will be held on
January 25, 2024, from 9 a.m. to 4:30
p.m., EST, and January 26, 2024, from
9 a.m. to 12 p.m., EST.
ADDRESSES: Zoom virtual meeting. If
you wish to attend the meeting, please
register in advance by accessing the link
at https://cdc.zoomgov.com/webinar/
register/WN_OHYkxlt_
QNyys3kLsfQ3Wg#/registration.
Instructions to access the meeting will
be provided following registration.
FOR FURTHER INFORMATION CONTACT:
Dometa Ouisley, Public Health Analyst,
Office of Science and Laboratory
Readiness, Office of Readiness and
Response, Centers for Disease Control
and Prevention, 1600 Clifton Road NE,
Mailstop H21–6, Atlanta, Georgia
30329–4027. Telephone: (404) 639–
7450; Email: DOuisley@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Board of Scientific
Counselors, Office of Readiness and
Response provides advice and guidance
to the Secretary, Department of Health
and Human Services (HHS); the
Assistant Secretary for Health, HHS; the
Director, Centers for Disease Control
and Prevention (CDC); and the Director,
Office of Readiness and Response
(ORR), CDC. The Board recommends
strategies and goals for readiness and
response activities pertaining to
programs and research within the
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:03 Dec 11, 2023
Jkt 262001
agency and the ORR divisions and
monitors the overall strategic direction
and focus of the ORR divisions and
offices. The Board also provides
administration and oversight of peer
review for ORR scientific programs. For
additional information about the Board,
please visit https://www.cdc.gov/orr/
bsc/index.htm.
Matters to be Considered: Agenda
topics for Day 1 will include: (1)
Organizational Update, (2) Division of
Readiness and Response Science
Overview, (3) Division Directors
Updates, and (4) Discussion: Growing
Science and Science Strategies. Agenda
topics for Day 2 will include: (1) Polio
Containment Working Group Updates,
(2) Health Equity Working Group
Updates, and (3) Discussion: Improving
Readiness for Future Threats. Agenda
items are subject to change as priorities
dictate.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2023–27170 Filed 12–11–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
86139
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Structural Biophysics.
Date: December 20, 2023.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dennis Pantazatos, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–2381, dennis.pantazatos@
nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: December 7, 2023.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–27198 Filed 12–11–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Initial Review Group Career
Development Education and Training Study
Section.
Date: February 23, 2024.
Time: 9:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Sindhu Kizhakke
Madathil, Ph.D., Scientific Review Officer,
E:\FR\FM\12DEN1.SGM
12DEN1
]]>Agencies
[Federal Register Volume 88, Number 237 (Tuesday, December 12, 2023)]
[Notices]
[Page 86139]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-27198]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Topics in Structural Biophysics.
Date: December 20, 2023.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dennis Pantazatos, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-2381,
[email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: December 7, 2023.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-27198 Filed 12-11-23; 8:45 am]
BILLING CODE 4140-01-P
